External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology AMP 2024
Roche and Genentech at

AMP 2024

November 19 - November 22
Vancouver, Canada
We will be contributing to topics related to
Oncology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
08:00 AM
Duration 1hr Vancouver, Canada
Simplifying the AVENIO Tumor Tissue CGP Manual Workflow: Performance of HRD, TMB, and MSI Signature Detection
Nan Zhang
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Vancouver, Canada
AVENIO Tumor Tissue CGP Automated Assay: End-to-End Solution with High Sample Pass Rate and Precision
Yuhang Li
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Vancouver, Canada
Comparative Analysis of Variant Reporting and HRD Performance: Evaluating AVENIO Tumor Tissue CGP Automated Assay Against F1CDx Assay and PGDx elio Test
Serena Li
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Vancouver, Canada
High Analytical Sensitivity and Specificity of the AVENIO Tumor Tissue CGP Automated Assay for Detecting Genomic Alterations in FFPE Tumor Tissue
Killeen Kirkconnell
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Vancouver, Canada
AVENIO Tumor Tissue CGP Automated Assay: End-to-End Solution With High Performance on NextSeq 500/550
James Blau
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Vancouver, Canada
An ultrasensitive kappa and lambda (K/L) dual in situ hybridization (ISH) mRNA assay for light chain restriction offers pre-analytical flexibility
Bowdoin Su
Oncology | B Cell Lymphoma

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Vancouver, Canada
Development of a PETE strategy for assessment of mutations associated with resistance to anti-CD20 therapy
Tyler Landrith
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:15 PM
Duration 1hr Vancouver, Canada
Genomics Annotation and Interpretation in Somatic Oncology with a Highly Structured Data Model
Jian Li
Oncology

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.